VAERS reports by lot

Novartis Vaccines Meningococcal lot 5P2P7: VAERS reports

24 VAERS reports list lot 5P2P7 as a Novartis Vaccines Meningococcal vaccine, received between 2023-02-22 and 2024-07-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1433%
Gastrointestinal716%
General / Systemic (non-local)614%
Musculoskeletal512%
Cardiac / Cardiovascular49%
Allergic / Anaphylactic37%
Neurological25%
Dermatological (non-injection-site)25%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas6
Pennsylvania3
Nevada3
Georgia2
Utah2
Iowa1
Minnesota1
Kansas1
California1
Michigan1
Idaho1
Colorado1

Reports by month received

2023-021
2023-031
2023-042
2023-051
2023-061
2023-074
2023-084
2023-093
2023-103
2023-111
2024-011
2024-061
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.